Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025,…
Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for…
BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to…
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 10, 2025 (GLOBE NEWSWIRE) — Revolo Biotherapeutics Limited (“Revolo”) today announced that it…
Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31,…
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Today,…
FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL AmyloidosisRMAT designation…
WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on…
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based…
Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model…